Comerica Bank Clovis Oncology, Inc. Transaction History

Comerica Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$12.81 - $25.67 $383,364 - $768,226	-29,927 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$17.66 - $30.28 $528,510 - $906,189	29,927 New	29,927 $0
Q4 2018 Feb 06, 2019	SELL	$11.63 - $32.67 $139,525 - $391,941	-11,997 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$29.37 - $49.48 $352,351 - $593,611	11,997 New	11,997 $241,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.